Substance Use Disorder

Adial’s AD04 for the treatment of alcohol use disorder received a Notice of Allowance from the US Patent and Trademark Office.

The Drug Policy Reform Act, introduced today, intends to decriminalize drug use and possession, providing health-centered approaches and rehabilitation instead.

How can understanding the opioid crisis in Canada inform strategies in the United States?

Healthy lungs are at risk—what can you do as a clinician to help patients quit vaping?

How can mental health professionals promote a true community of immunity?

As all eyes were on the pandemic, another surge simmered below the surface.

The COVID-19 pandemic has exacerbated mental health and gender inequalities around the world. Understanding the causes is the first step toward finding solutions.

According to Nora D. Volkow, MD, Director of the National Institute on Drug Abuse, drug use and overdose deaths have significantly increased since the outset of the pandemic. What made it worse?

The Drug Enforcement Administration has freed this formerly schedule II controlled substance.

Looking to reduce youth initiation into tobacco products, the FDA takes steps against menthol cigarettes and flavored cigars.

Government funding for the drug addiction crisis is on the way.

The sharply decreasing perception of risk and easy accessibility of cannabis has many patients turning towards it, despite the potential negative effects.

The rapidly changing field of cannabinoids and their clinical implications poses a particular challenge in psychiatry.

A synthesis of quantitative reviews on the relationship between cannabis use and psychosis.

Psychiatrists face diagnostic puzzles almost every day. Find out how one clinician cracked a tough case.

An alcohol use disorder treatment has 4 potential advantages over existing treatments.

With opioid use disorder, a tiny fraction of young patients are getting treatment, which would not be acceptable for any other medical condition.

The Department of Health and Human Services moves to reduce administrative procedural barriers to OUD treatment.

In an ADAPT-2 study, a combination of injectable naltrexone and oral bupropion showed promise for methamphetamine users.

Are patients with depression and substance use disorder getting an appropriate level of care? Our Journal Club piece investigates.

According to a recent study, certain product combinations of alcohol and cannabis may be less likely to cause negative consequences.

Female emergency department patients with adverse childhood experiences were more likely to have substance use issues.

A significant proportion of incarcerated individuals struggle with with addiction. So what is being done about it?

New research is being conducted on how psychedelic substances may change the future of mental health care. Dr Carlin explained more in her speech at the Annual Psychiatric Times® World CME Conference™.

Inevitably, some of your patients will need of emergency psychiatric services. These tips will help prepare you and your patients when a crisis unfolds.

Consumption of cannabis during pregnancy results in a host of problems, including cannabinoid placental crossing and accumulation in the fetal brain as well as other organs.

This innovative program at Massachusetts General Hospital addresses postoperative pain while preventing relapse in patients a history of opioid use disorder.

As the COVID-19 pandemic continues to affect the country, SAMHSA and the DEA allow for flexibility in addressing the needs of patients with opioid use disorder.

How much progress has been made in the area of substance use disorders in the last 40 years?